BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the commercial launch of the first in a family of high-throughput, robotics-compatible reagent kits that will enable automation to ensure greater consistency and increased efficiency of large-scale, single-cell discovery studies.

Recently, Shanghai University, relying on Shanghai's scientific and educational resources, gave full play to the cross-integration of multiple disciplines such as machinery and control, and the national first-class discipline of "mechanical engineering"

Robotics in medtech are quickly becoming common place as the number of companies in the market continue to grow. On June 12, seasoned veterans of robotic surgery companies will share their thoughts about the state of surgical robotics techno